Prognostic impact of C-KIT mutations in Core Binding Factor-Leukemia.

被引：0
|
作者：
Cairoli, R
Beghini, A
Nadali, G
Elice, F
Lunghi, M
Cuneo, A
Grillo, G
Nichelatti, M
Ripamonti, CB
Lazzarino, M
Rodeghiero, F
Pizzolo, G
Larizza, L
Morra, E
机构：
[1] Niguarda Hosp, Dept Hematol, Milan, Italy
[2] Univ Milan, Dept Biol & Genet, Milan, Italy
[3] Policlin G Rossi, Dept Hematol, Verona, Italy
[4] S Bortolo Hosp, Dept Hematol, Vicenza, Italy
[5] Policlin San Matteo, IRCCS, Dept Hematol, Pavia, Italy
[6] St Anna Hosp, Dept Hematol, Ferrara, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2013.2013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2013
引用
收藏
页码：555A / 555A
页数：1
相关论文
共 50 条
  • [21] Detection of C-KIT Mutations in Acute Myeloid Leukemia
    Szankasi, P.
    Ho, A. K.
    Kelley, T. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 630 - 630
  • [22] Prognostic Impact of Kinase Mutations and Minimal Residual Disease in Core-Binding Factor Leukemia
    Sanford, David
    Cortes, Jorge E.
    Ravandi, Farhad
    Qiao, Wei
    Patel, Keyur P.
    Hoang, Thuyvan
    Kadia, Tapan
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2015, 126 (23)
  • [23] The role of C-KIT mutations in the leukemogenesis of core-binding factor acute mycloid leukemia: A comparative analysis on paired diagnosis and relapse samples.
    Liang, Der-Chemg
    Shih, Lee-Yung
    Huang, Chein-Fuang
    Chang, Ya-Tzu
    Li, Huei-Ying
    Lai, Chang-Liang
    BLOOD, 2006, 108 (11) : 654A - 654A
  • [24] Study on the Pathogenesis and Clinical Significance of FLT3 and C-KIT Mutations in Core-Binding Factor AML
    Sun, Aining
    Ji Shimeng
    Chen, Suning
    Zhang, Tongtong
    Wu, Depei
    BLOOD, 2016, 128 (22)
  • [25] Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias
    Care, RS
    Valk, PJM
    Goodeve, AC
    Abu-Duhier, FM
    Geertsma-Kleinekoort, WMC
    Wilson, GA
    Gari, MA
    Peake, IR
    Löwenberg, B
    Reilly, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) : 775 - 777
  • [26] Prognostic Impact of RAS and C-KIT Mutations (Single vs. Multiple) in Core-Binding Factor Acute Myeloid Leukemia (CBFAML) Treated With a Fludarabine, Cytarabine, and G-CSF (FLAG)-Based Regimen
    Abuasab, Tareq
    Senapati, Jatastu
    Kadia, Tapan
    Ravandi, Farhad
    DiNardo, Courtney
    Pemmaraju, Naveen
    Ohanion, Maro
    Alvarado, Yesid
    Kantarjian, Hagop
    Borthakur, Gautam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S235 - S236
  • [27] Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome
    Markova, Jana
    Trnkova, Zuzana
    Michkova, Petra
    Maaloufova, Jacqueline
    Stary, Jan
    Cetkovsky, Petr
    Schwarz, Jiri
    LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1448 - 1460
  • [28] Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia
    Tan, Yanhong
    Liu, Zhuang
    Wang, Wenjun
    Zhu, Guiyang
    Guo, Jianli
    Chen, Xiuhua
    Zheng, Chaofeng
    Xu, Zhifang
    Chang, Jianmei
    Ren, Fanggang
    Wang, Hongwei
    LEUKEMIA RESEARCH, 2018, 69 : 89 - 93
  • [29] Clinical implications of c-Kit mutations in acute myelogenous leukemia
    Malaise M.
    Steinbach D.
    Corbacioglu S.
    Current Hematologic Malignancy Reports, 2009, 4 (2) : 77 - 82
  • [30] Incidence and prognosis of c-kit and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.
    Care, RS
    Goodeve, AC
    Abu-Duhier, FM
    Geertsma-Kleinekoort, W
    Valk, PJM
    Lowenberg, B
    Wilson, GA
    Gari, MA
    Peake, IR
    Reilly, JT
    BLOOD, 2002, 100 (11) : 746A - 746A
12345